Dermatology Therapeutics Market to 2017 - Alopecia market is Forecast to Decline

Nov. 11, 2011 - PRLog -- “Dermatology Therapeutics Market to 2017 - Alopecia market is Forecast to Decline Due to Patent Expiry of Finasteride in 2013 and Weak Pipeline”, which provides insights into dermatology therapeutics marled until 2017. The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts. The report provides an in-depth analysis of the major dermatology diseases including Herpes Zoster, Herpes Simplex, Psoriasis, Alopecia, Rosacea, Atopic Dermatitis and Acne. The report also provides the share of generics in global dermatology diseases as well as in each indication market. The report examines the global dermatology diseases treatment usage patterns. In addition, the geographical distribution of dermatology diseases and market across the US, the top five countries of Europe and in Japan are provided in the report. The report also includes insights into the dermatology diseases R&D product pipeline and explores the competitive landscape including major players in dermatology diseases therapeutics market.

For Sample Pages, please click or add the below link to your browser:
http://www.globalmarketsdirect.com/SamplePdfRequest.aspx?...

Scope of the report:
Data and analysis on the dermatology therapeutics market in the leading geographies of the world – the US, the UK, Germany, France, Italy, Spain, and Japan.
Annualized market data for the dermatology therapeutics market from 2002 to 2010, with forecasts to 2017.
Market data on the geographical landscape and therapeutic landscape, including market size, market share, annual cost of therapy, sales volume and treatment usage patterns such as disease population, treatment seeking population, diagnosis population and prescription population.
Key drivers and restraints that have had a significant impact on the market.
The competitive landscape of the global autoimmune diseases market including top companies benchmarking.
Key M&A activities and Licensing Agreements that took place in 2009 and 2011 in the dermatology therapeutics market.

Why you need this report:
Align your product portfolio to the markets with high growth potential.
Build effective strategies to launch their pipeline products by identifying potential geographies.
Exploit in-licensing and out-licensing opportunities by identifying products that might fill their portfolio gaps.
Develop key strategic initiatives by studying the key strategies of top competitors.
Develop market-entry and market expansion strategies by identifying the geographic markets poised for strong growth.
Reinforce R&D pipelines by identifying new target mechanisms which can produce first-in-class molecules which are safer and more efficacious.

Do follow us at facebook:
http://www.facebook.com/PharmaceuticalsandHealthcareMarke...
Visit our report store: http://www.globalmarketsdirect.com

For more details contact:
pressreleases@globalmarketsdirect.com
North America:    +1 646 395 5477
Europe:        +44 207 753 4299
           +44 1204 543 533
Asia Pacific:       +91 40 6616 6782